Back

A deep learning-generated hASIC1a miniprotein inhibitor confers neuroprotection in stroke

Sormann, J.; Epitropaki, K.; Vicino, M. F.; Fjorbak, C. L.; Pugh, C. F.; Lang, B.; Beyer, E. K.; Comaposada-Baro, R.; Hink, F.; Friis, S.; Usher, S. G.; Cai, C.; Autzen, H. E.; Rogers, J. M.; Pless, S.

2026-10-09 biophysics
10.64898/2026.10.04.755611 bioRxiv
Show abstract

Ion channels remain notoriously recalcitrant drug targets despite their extensive pathophysiological significance. Acid-sensing ion channels (ASICs) are proton-gated cation channels that cause neuronal death when excessively activated, such as during ischaemic stroke. This acidosis-driven injury pathway remains unchallenged by existing therapeutics. Here we generate two de novo designed hASIC1a-specific miniproteins by developing a platform that integrates computational miniprotein design, high-throughput automated patch clamp screening, biophysical and structural characterisation, and in vivo validation. We identify a subtype-selective hASIC1a inhibitor, Denasin1, which achieves near-complete inhibition with nanomolar potency. Denasin1 is disordered in solution but adopts the computationally predicted helix-turn-helix fold when bound to the extracellular acidic pocket of hASIC1a. Crucially, Denasin1 reduces infarct volume by > 50% in a murine model of ischaemic stroke. We thereby establish our de novo design platform as a route to develop potent and selective ion channel modulators.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.